RENOVA® (tretinoin cream) 0.02% is a serious medication that may help treat but will not "cure" fine wrinkles, spotty skin discoloration, and rough feeling skin. RENOVA 0.02% will not repair skin, eliminate wrinkles, or reverse aging.
RENOVA should be used as part of a broad skin care program that includes avoiding direct sunlight (by using protective clothing and sunscreens with a minimum SPF of 15) and using other moisturizing facial creams.
Important Safety Information
Do not use RENOVA if you are pregnant or trying to become pregnant.
Tell your doctor about any other medications or skin creams you are using. RENOVA increases your sensitivity to sunlight and should not be used with other medications or skin care products that increase sensitivity to sunlight.
You should not use RENOVA if you are sunburned or highly sensitive to the sun, if you have eczema, or if your skin is irritated. Remember to limit your time in the sun, and always wear a sunscreen with SPF 15 or higher.
RENOVA has not been studied for daily use beyond 12 months.
RENOVA 0.02% is a skin irritant. Almost all patients experience one or more local skin reactions, including dryness, peeling, burning/stinging, redness
RENOVA 0.02% WILL NOT REPAIR SKIN, ELIMINATE WRINKLES, OR REVERSE AGING.
View Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
References:1. Wolters Kluwer Health, Source® PHAST data, July 2011–August 2012. 2. Kircik LH. Safety and efficacy evaluation of tretinoin cream 0.02% for the reduction of photodamage: a pilot study. J Drugs Dermatol. 2012;11(1):83-90. 3. Kircik LH. Clinical update: the clinical efficacy and safety of tretinoin for the treatment of aging skin. Skin & Allergy News. 2009;(suppl):1-4. 4. RENOVA [prescribing information]. Bridgewater, NJ: Valeant Dermatology, a division of Valeant Pharmaceuticals North America LLC; 2012. 5. Data on file. Valeant Pharmaceuticals. 6. Nyirady J, Bergfeld W, Ellis C, et al. Tretinoin cream 0.02% for the treatment of photodamaged facial skin: a review of 2 double-blind clinical studies. Cutis. 2001;68(2):135-142.